Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
REWIND Investigators Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Corrected Sodium Calculator Estimate sodium corrected for hyperglycemia using common 1.6 and 2.4 correction factors
Truveta Data brings together linked EHR and claims data for more than 130 million patients, enabling researchers to study safety, effectiveness, and outcomes across diverse populations in routine care
Repertoire of equine -defensins Bruhn et al
Experts warn about nutritional deficiencies with weight loss drugs
December 20 Product: Zealands glepaglutide Indication: Short bowel syndrome The FDA on Thursday shot down Zealand Pharmas aspirations to use its investigational GLP-2 analog glepaglutide for the treatment of short bowel syndrome
US$ 25.53
US$ 21.89
US$ 27.80
